Kings Path Partners’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Hold
16,570
0.12% 69
2026
Q1
$401K Hold
16,570
0.14% 72
2025
Q4
$401K Hold
16,570
0.14% 72
2025
Q3
$423K Hold
16,570
0.16% 70
2025
Q2
$357K Sell
16,570
-4,245
-20% -$95.7K 0.14% 74
2025
Q1
$475K Sell
20,815
-13,100
-39% -$345K 0.23% 59
2024
Q4
$880K Hold
33,915
0.38% 70
2024
Q3
$849K Sell
33,915
-4,711
-12% -$111K 0.36% 72
2024
Q2
$828K Buy
+38,626
New +$750K 0.39% 68

Other funds holding BLFS

Kings Path Partners's BLFS Position: Q2 2026 in Review

Kings Path Partners held its BioLife Solutions (BLFS) position steady in Q2 2026 at 16,570 shares worth $468K. The position accounts for 0.12% of the portfolio, ranked #69.

Kings Path Partners first reported a position in BLFS in Q2 2024 and has held it in 9 quarters since. The position peaked at $880K in Q4 2024. 18 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Kings Path Partners held 16,570 shares of BioLife Solutions worth $468K as of Q2 2026.
  • Kings Path Partners left its BioLife Solutions share count unchanged in Q2 2026.
  • BioLife Solutions made up 0.12% of Kings Path Partners's portfolio in Q2 2026, its #69 holding.
  • Kings Path Partners first reported a position in BioLife Solutions in Q2 2024 and has held it in 9 quarters since.
  • Kings Path Partners's BioLife Solutions position peaked at $880K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.